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F. Dick*
Division of Cardio-Vascular Surgery, University Hospital Berne, Freiburgstrasse, 3010 Bern, SwitzerlandThis issue of the Journal features a vitally important paper
which, hopefully, heralds a new era of complementary reporting of
vascular care. The VASCUNET Committee, a group of National
vascular registry representatives supported by the European
Society for Vascular Surgery (ESVS), presents its ﬁrst peer-
reviewed report on surgical practice pattern for peripheral arte-
rial occlusive disease (PAOD) within nine countries across Europe
and Australia.1 The sheer size of more than 32,000 analyzed
peripheral bypass procedures warrants a powerful voice to its
ﬁndings that cannot be ignored. Unlike previous population-based
surveys,2 the VASCUNET report presents stratiﬁed data on bypass
level and choice of conduit according to PAOD severity. Thus it
offers, at least theoretically, a unique opportunity to assess
whether practice recommendations3,4 are actually reﬂected in
clinical reality.
Why is such appraisal so important? Apart from external vali-
dation of guideline applicability and identiﬁcation of conﬂicting
evidence, population-based appraisal is essential to support cred-
ibility of surgical treatment options that are increasingly challenged
by less invasive alternatives, such as in PAOD.4,5 Thereby, the
VASCUNET report highlights two crucial aspects. First, that it is
feasible at all to collaborate across national boundaries to amal-
gamate individual registry data successfully. And second, how
unexpectedly difﬁcult it may turn out to extract clinically mean-
ingful evidence from such meta-registries.
Data completeness and validity (i.e., representativeness) repre-
sent the obvious challenges in any population-based research. The
authors of the VASCUNET report have highlighted the variable
limitations regarding data audit and validation process across the
participating countries and share their concerns about uncertain
data quality with us. Thus, interpretation of variations regarding
both demographic patient proﬁles and practice pattern remains
difﬁcult due to potential confounding or bias.
Far more astonishing, however, are the seeming difﬁculties to
agree to the nature of baseline characteristics and outcomeDOI of original article: 10.1016/j.ejvs.2012.05.006.
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accepted reporting standards.5,6 Admittedly, the ‘art of the feasible’
mandates reduction to minimal datasets, in particular for registries
with voluntary data capture. However, extractable information
should still make sense clinically.
It is interesting that almost none of the involved registries
(many of which are run by the respective National vascular surgery
societies) captured certain essential clinical information. For
instance, how can it be explained that the VASCUNET countries
performed roughly 10 times less bypass procedures per 100,000
population than the US in the same period?2 In other words, what
proportions were treated by valid alternatives such as supervised
exercise or endovascular intervention,3 or were not treated at all? It
seems unlikely that the endovascular shift should have been much
more pronounced than in the US where almost 80% of PAOD
patients were treated by endovascular means already in 2006. Or,
what was the penetration of best medical treatment among this
high risk population? This quality measure of overall vascular care
is essential for surgical patients as much as for any other.3 And
lastly, what was the clinical outcome of bypass surgery beyond 30
days?
The lack of outcome information is particularly concerning
when considering that some reported quality indicators did not
comply at all with current practice guidelines.3,4 Synthetic graft
materials were overused to an incredible extent: up to 70% of
claudicants received synthetic conduits, as did up to 50% of those
with critical limb ischemia in some countries! Even for extreme
indications such as below the knee bypass for ischemic tissue loss
overall use of synthetic conduits reached 20%. Moreover, up to 40%
of all surgical bypasses were applied to non-threatened, claudi-
cating limbs, i.e. for relative indications. Perhaps as a consequence
of the above, patency rates at 30 days remained signiﬁcantly below
the expected.
More than anything else, these ﬁndings highlight the urgent
need for conjoint efforts to improve monitoring and reporting of
delivered treatment quality in clinical practice. Wherever national
obligations are lacking, the vascular societies will have to assume
the responsibility to implement, supervise and audit meaningful
quality control and improvement programmes with mandatory
reporting of minimal datasets. Supranational societies such as thed by Elsevier Ltd. All rights reserved.
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datapoints in accordance with society reporting standards and to
enforce uniform deﬁnitions in view of international audits. The
VASCUNET initiative has just demonstrated how difﬁcult
such coordinations are. However, without comprehensive demon-
stration of reproducible treatment quality outside controlled
studies, the credibility of our daily practice is at stake.
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